Levocetirizine Dihydrochloride Tablet, Coated
Product Images NDC 63868-473

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 63868-473). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chain Drug Marketing Association Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

This is a description of a medication used to temporarily relieve allergy symptoms, such as runny nose, sneezing, itchy and watery eyes, and itching of the nose or throat. It contains Levocetirizine dihydrochloride, an antihistamine, and comes in 5 mg tablets, with instructions for use in adults and children between the ages of 6-64, as well as warnings for those with kidney disease, history of allergic reactions, or difficulty urinating. The medication should be stored at room temperature and kept out of reach of children. For questions or comments, consumers can contact the manufacturer at a provided phone number.*

FDA Label Image

Carton (Carton)

This is a drug fact sheet with information on Levocetirizine Dihydrochloride Tablets, which is the generic form of Xyzal Allray 24HR for allergy relief. The tablets come in a 5 mg strength and are meant to provide relief from symptoms such as sneezing, runny nose, itchy nose or throat, and itchy and watery eyes. It is clinically proven to provide relief in 60 minutes and to last for 24 hours. Directions for use are not clear in the provided text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.